Revefenacin photograph

Revefenacin

Use attributes for filter !
Trade nameYupelri
FormulaC35H43N5O4
ChemSpider ID9928376
PubChem CID11753673
Music groups Tiotropium bromide
Formoterol
Date of Reg.
Date of Upd.
ID2018727
Send edit request

About Revefenacin


Revefenacin is a pharmaceutical drug for the treatment of chronic obstructive pulmonary disease. It was approved for use in the United States in 2018. It was developed by Theravance Biopharma and is marketed by Mylan. Revefenacin is formulated as a solution that is nebulized and inhaled.

Revefenacin Photos

Related Persons

Next Profile ❯